combination of glycine and GABA antagonists (University of California Davis)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namecombination of glycine and GABA antagonists (University of California Davis)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionGlycine receptor antagonistsGABA-B receptor 1 inhibitorsGamma-aminobutyric acid A receptor antagonists
TargetsGABA-B receptor 1Glycine receptorGamma-aminobutyric acid A receptor
Therapy Area/IndicationsPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of California Davis
Active IndicationsN/A
Inactive IndicationsPruritus

Other Information

ATC CodeN/A
Related LinksN/A